Schering-Plough Corp. said it has sued Thousand...
- Share via
Times Staff and Wire Reports
Schering-Plough Corp. said it has sued Thousand Oaks-based Amgen Inc., accusing it of infringing a patent owned by Cambridge, Mass.-based Biogen Inc. covering treatments for the liver disease hepatitis C. . . .
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.